Shopping Cart
- Remove All
- Your shopping cart is currently empty
LY310762 is a 5-HT1D receptor antagonist with Ki of 249 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $29 | In Stock | |
10 mg | $43 | In Stock | |
25 mg | $88 | In Stock | |
50 mg | $142 | In Stock | |
100 mg | $229 | In Stock | |
200 mg | $347 | In Stock | |
1 mL x 10 mM (in DMSO) | $29 | In Stock |
Description | LY310762 is a 5-HT1D receptor antagonist with Ki of 249 nM. |
Targets&IC50 | 5-HT1D:249 nM(Ki) |
In vitro | Following treatment with LY310762, the levels of 5-HT in animals treated with fluoxetine increased from 312±43% to a peak of 683%. In the control group, the 5-HT levels remained constant at 250%. Compared to animals that received a control vehicle injection, systemic administration of 10 mg/kg i.p. LY310762 significantly enhanced the response of 5-HT to 20 mg/kg i.p. fluoxetine. When administered alone, LY310762 notably raised the baseline levels of 5-HT above the vehicle control, achieving a maximum value of 258% compared to the pre-injection control group. |
In vivo | LY310762 enhances potassium-induced [3H] 5-HT efflux from guinea pig cortical slices, with an EC50 of 30 nM. The maximal enhancement of potassium-induced [3H]5-HT efflux by LY310762 is approximately 40%. LY310762 exhibits a higher affinity for the guinea pig 5-HT1D receptor than for the 5-HT1B receptor. |
Alias | LY310762 HCl |
Molecular Weight | 430.94 |
Formula | C24H27FN2O2·HCl |
Cas No. | 192927-92-7 |
Smiles | Cl.CC1(C)C(=O)N(CCN2CCC(CC2)C(=O)c2ccc(F)cc2)c2ccccc12 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 43.1 mg/mL (100 mM) H2O: 4.3 mg/mL (10 mM) | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.